- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有558家主力机构披露2024-06-30报告期持股数据，持仓量总计45.75亿股，占流通A股57.88%
- 波段诊断：
-
技术面诊股
诊断结果：2.6技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为14.96元。
平均成本
近期的平均成本为14.96元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.96","date":1732090756,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2024.11.21","stock":"-1.18","trade":"-0.44","ind":"-0.07"},{"date":"2024.11.20","stock":"-0.46","trade":"2.72","ind":"0.78"},{"date":"2024.11.19","stock":"2.48","trade":"2.39","ind":"1.90"},{"date":"2024.11.18","stock":"-1.33","trade":"-3.50","ind":"-1.91"},{"date":"2024.11.15","stock":"-3.21","trade":"-3.11","ind":"-2.62"},{"date":"2024.11.14","stock":"-4.71","trade":"-3.97","ind":"-2.83"},{"date":"2024.11.13","stock":"-2.56","trade":"-1.49","ind":"0.40"},{"date":"2024.11.12","stock":"3.26","trade":"1.61","ind":"-0.65"},{"date":"2024.11.11","stock":"1.18","trade":"2.97","ind":"2.03"},{"date":"2024.11.08","stock":"-2.61","trade":"0.47","ind":"-0.66"},{"date":"2024.11.07","stock":"8.91","trade":"2.80","ind":"2.44"},{"date":"2024.11.06","stock":"-0.33","trade":"0.63","ind":"-0.35"},{"date":"2024.11.05","stock":"5.12","trade":"3.90","ind":"3.22"},{"date":"2024.11.04","stock":"1.97","trade":"2.62","ind":"1.99"},{"date":"2024.11.01","stock":"-2.14","trade":"-2.50","ind":"-1.28"},{"date":"2024.10.31","stock":"1.05","trade":"0.69","ind":"0.57"},{"date":"2024.10.30","stock":"-2.52","trade":"-2.07","ind":"-0.12"},{"date":"2024.10.29","stock":"-2.45","trade":"-2.51","ind":"-1.33"},{"date":"2024.10.28","stock":"0.67","trade":"2.57","ind":"0.62"},{"date":"2024.10.25","stock":"4.03","trade":"4.70","ind":"1.71"},{"date":"2024.10.24","stock":"-2.57","trade":"-0.70","ind":"-1.27"}]
爱尔眼科,深证成指,医疗服务指数
压力支撑
该股压力位为14.96元，支撑位为14.81元。
[{"text":"\u538b\u529b\u4f4d","value":"14.96","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.81","date":1732118400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了17%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月21日 20:33
| 机构今日流向(万元) | -1048.65 | 机构5日流向(万元) | -5328.41 |
| 机构10日流向(万元) | -14991.37 | 机构20日流向(万元) | -8125.28 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少48335.61万股，其中基金净减仓73家，主力净减仓147家，请投资者中长期谨慎为宜。
截止2024-06-30，共558家主力机构（基金555家，券商集合理财1家，一般法人2家），持仓量总计457547.19万股，占流通A股57.88%
其中，基金持仓与2023-12-31相比：
增仓：154家 ，增持 14986.81万股
减仓：227家 ，减持 25879.67万股
新出现在主力名单中：115家 ，持有4264.12万股
从主力名单中消失：262家 ，原持有26178.13万股
其中，基金持仓与2023-12-31相比：
增仓：154家 ，增持 14986.81万股
减仓：227家 ，减持 25879.67万股
新出现在主力名单中：115家 ，持有4264.12万股
从主力名单中消失：262家 ，原持有26178.13万股
消息面诊股
诊断结果：5.5消息面打败了28%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 爱尔眼科：公司的视光业务是从预防、控制到治疗的完整
2024-11-21 - 爱尔眼科：专注于眼科医疗，为广大患者提供高质量服务
2024-11-21 - 爱尔眼科：11月20日融券卖出金额19.29万元
2024-11-21 - 爱尔眼科：已在2024年半年度报告中介绍推动医教研
2024-11-21 - 旗下4家医院涉嫌出具虚假诊断证明，爱尔眼科称已整改
2024-11-20 - 昆明爱尔眼科医院入选中国近视防控能力建设联盟骨干级
2024-11-20 - 爱尔眼科：涉事医院已按要求整改，集团将持续坚持刀刃
2024-11-20 - 被卫健委披露涉嫌造假与行贿，爱尔眼科要面对的难题不
2024-11-20 - 爱尔眼科：11月19日获融资买入1.79亿元，占当
2024-11-20 - 国家卫健委回复艾芬信访：多家爱尔眼科医院涉嫌出具虚
2024-11-19
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-28 |
| 一般消息 | 募资投向 | 2024-09-20 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-24 |
| 一般消息 | 重大事项 | 关联交易 | 2024-08-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-07-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-07-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-05-31 |
| 利好 | 分红转增 | 10派1.500225元(含税) | 2024-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-03-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-01-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.4行业面打败了77%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.21","price":"-0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.78","value":"2.72"},{"date":"2024.11.19","price":"1.90","value":"2.39"},{"date":"2024.11.18","price":"-1.91","value":"-3.50"},{"date":"2024.11.15","price":"-2.62","value":"-3.11"},{"date":"2024.11.14","price":"-2.83","value":"-3.97"},{"date":"2024.11.13","price":"0.40","value":"-1.49"},{"date":"2024.11.12","price":"-0.65","value":"1.61"},{"date":"2024.11.11","price":"2.03","value":"2.97"},{"date":"2024.11.08","price":"-0.66","value":"0.47"},{"date":"2024.11.07","price":"2.44","value":"2.80"},{"date":"2024.11.06","price":"-0.35","value":"0.63"},{"date":"2024.11.05","price":"3.22","value":"3.90"},{"date":"2024.11.04","price":"1.99","value":"2.62"},{"date":"2024.11.01","price":"-1.28","value":"-2.50"},{"date":"2024.10.31","price":"0.57","value":"0.69"},{"date":"2024.10.30","price":"-0.12","value":"-2.07"},{"date":"2024.10.29","price":"-1.33","value":"-2.51"},{"date":"2024.10.28","price":"0.62","value":"2.57"},{"date":"2024.10.25","price":"1.71","value":"4.70"},{"date":"2024.10.24","price":"-1.27","value":"-0.70"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 奥浦迈 | 33.94% | 0.02% | 5.3分 |
| 2 | 皓宸医疗 | 31.03% | -12.64% | 4.9分 |
| 3 | 毕得医药 | 30.39% | 3.93% | 5.1分 |
| 4 | 美年健康 | 28.64% | 4.70% | 5.7分 |
| 5 | 普瑞眼科 | 20.99% | -10.26% | 4.7分 |
| 6 | 创新医疗 | 18.19% | -9.24% | 4.0分 |
| 8 | 博腾股份 | 16.11% | -6.05% | 3.2分 |
| 10 | 澳洋健康 | 13.59% | 2.52% | 4.8分 |
| 12 | 诺思格 | 11.26% | -2.23% | 4.7分 |
| 14 | 和元生物 | 10.34% | -4.95% | 4.6分 |
| 16 | 贝瑞基因 | 9.88% | 3.38% | 5.0分 |
| 18 | 诺禾致源 | 9.18% | 0.97% | 5.4分 |
| 20 | 光正眼科 | 8.79% | -4.75% | 4.8分 |
| 22 | 新里程 | 8.66% | -2.13% | 4.5分 |
| 24 | 皓元医药 | 6.64% | -7.50% | 4.7分 |
| 26 | 药康生物 | 6.11% | 0.15% | 4.9分 |
| 28 | 何氏眼科 | 4.65% | -3.28% | 4.0分 |
| 30 | 九洲药业 | 4.47% | 0.45% | 4.5分 |
| 32 | 药明康德 | 4.05% | -4.10% | 4.6分 |
| 34 | 华厦眼科 | 3.50% | -4.70% | 4.4分 |
| 36 | 博济医药 | 1.54% | -0.22% | 4.5分 |
| 38 | 阳光诺和 | 1.30% | -4.83% | 5.2分 |
| 40 | 泓博医药 | 0.31% | -3.34% | 4.9分 |
| 42 | 睿智医药 | 0.15% | -0.15% | 4.2分 |
| 44 | 万邦医药 | -0.60% | -0.90% | 4.7分 |
| 46 | 兰卫医学 | -1.48% | 2.01% | 4.6分 |
| 48 | 成都先导 | -2.24% | -8.12% | 4.2分 |
| 50 | 泰格医药 | -2.74% | 0.12% | 5.3分 |
| 52 | 百花医药 | -3.86% | -2.30% | 4.5分 |
| 54 | - | - | 153.01% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/96 ， 7/96。
[{"date":"2024-09-30","value":"17.58","vol":"3.45"},{"date":"2024-06-30","value":"10.71","vol":"2.65"},{"date":"2024-03-31","value":"4.67","vol":"1.13"},{"date":"2023-12-31","value":"18.91","vol":"4.72"},{"date":"2023-09-30","value":"17.99","vol":"6.22"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.58 | 10.71 | 4.67 | 18.91 | 17.99 |
| 行业(%) | 3.45 | 2.65 | 1.13 | 4.72 | 6.22 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"51.02","vol":"36.79"},{"date":"2024-06-30","value":"49.44","vol":"36.95"},{"date":"2024-03-31","value":"48.29","vol":"36.12"},{"date":"2023-12-31","value":"50.79","vol":"39.51"},{"date":"2023-09-30","value":"51.93","vol":"40.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
51.02 | 49.44 | 48.29 | 50.79 | 51.93 |
| 行业(%) | 36.79 | 36.95 | 36.12 | 39.51 | 40.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/96 ， 12/96。
[{"date":"2024-09-30","value":"1.58","vol":"2.30"},{"date":"2024-06-30","value":"2.86","vol":"2.66"},{"date":"2024-03-31","value":"3.50","vol":"4.69"},{"date":"2023-12-31","value":"26.43","vol":"10.34"},{"date":"2023-09-30","value":"22.95","vol":"9.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.58 | 2.86 | 3.50 | 26.43 | 22.95 |
| 行业(%) | 2.30 | 2.66 | 4.69 | 10.34 | 9.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"8.50","vol":"-152.72"},{"date":"2024-06-30","value":"19.71","vol":"-97.56"},{"date":"2024-03-31","value":"15.16","vol":"-46.85"},{"date":"2023-12-31","value":"33.07","vol":"0.01"},{"date":"2023-09-30","value":"34.97","vol":"-386.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
8.50 | 19.71 | 15.16 | 33.07 | 34.97 |
| 行业(%) | -152.72 | -97.56 | -46.85 | 0.01 | -386.50 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 3/96 ， 17/96。
[{"date":"2024-09-30","value":"0.52","vol":"0.31"},{"date":"2024-06-30","value":"0.34","vol":"0.20"},{"date":"2024-03-31","value":"0.17","vol":"0.10"},{"date":"2023-12-31","value":"0.72","vol":"0.43"},{"date":"2023-09-30","value":"0.57","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.52 | 0.34 | 0.17 | 0.72 | 0.57 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.43 | 0.32 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"7.97","vol":"13.99"},{"date":"2024-06-30","value":"5.66","vol":"8.71"},{"date":"2024-03-31","value":"3.21","vol":"4.51"},{"date":"2023-12-31","value":"12.29","vol":"19.08"},{"date":"2023-09-30","value":"10.07","vol":"11.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
7.97 | 5.66 | 3.21 | 12.29 | 10.07 |
| 行业(次) | 13.99 | 8.71 | 4.51 | 19.08 | 11.28 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"25.28","vol":"12.31"},{"date":"2024-06-30","value":"29.02","vol":"10.34"},{"date":"2024-03-31","value":"24.84","vol":"0.77"},{"date":"2023-12-31","value":"6.89","vol":"24.44"},{"date":"2023-09-30","value":"38.05","vol":"16.37"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 25.28 | 29.02 | 24.84 | 6.89 | 38.05 |
| 行业 | 12.31 | 10.34 | 0.77 | 24.44 | 16.37 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.02","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.88","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.02 | - | 0.88 | - |
| 行业 | 0.00 | 1.47 | 0.00 | 2.51 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/96 ， 5/96。
[{"date":"2024-09-30","value":"1.37","vol":"4.06"},{"date":"2024-06-30","value":"1.42","vol":"4.09"},{"date":"2024-03-31","value":"1.84","vol":"4.35"},{"date":"2023-12-31","value":"1.69","vol":"4.20"},{"date":"2023-09-30","value":"1.70","vol":"4.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.37 | 1.42 | 1.84 | 1.69 | 1.70 |
| 行业 | 4.06 | 4.09 | 4.35 | 4.20 | 4.21 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.17","vol":"3.34"},{"date":"2024-06-30","value":"1.24","vol":"3.35"},{"date":"2024-03-31","value":"1.67","vol":"3.57"},{"date":"2023-12-31","value":"1.51","vol":"3.49"},{"date":"2023-09-30","value":"1.54","vol":"3.65"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.17 | 1.24 | 1.67 | 1.51 | 1.54 |
| 行业 | 3.34 | 3.35 | 3.57 | 3.49 | 3.65 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/96 ， 18/96。
[{"date":"2024-09-30","value":"34.69","vol":"31.14"},{"date":"2024-06-30","value":"35.03","vol":"31.74"},{"date":"2024-03-31","value":"32.28","vol":"31.10"},{"date":"2023-12-31","value":"33.66","vol":"32.13"},{"date":"2023-09-30","value":"33.76","vol":"30.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
34.69 | 35.03 | 32.28 | 33.66 | 33.76 |
| 行业(%) | 31.14 | 31.74 | 31.10 | 32.13 | 30.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.56","vol":"0.84"},{"date":"2024-06-30","value":"0.57","vol":"0.86"},{"date":"2024-03-31","value":"0.51","vol":"0.91"},{"date":"2023-12-31","value":"0.54","vol":"1.05"},{"date":"2023-09-30","value":"0.54","vol":"1.70"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.56 | 0.57 | 0.51 | 0.54 | 0.54 |
| 行业(%) | 0.84 | 0.86 | 0.91 | 1.05 | 1.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 方正证券 | 2024-11-18 | 增持 | 增持 |
| 兴业证券 | 2024-11-10 | 买入 | |
| 东北证券 | 2024-11-09 | 买入 | 买入 |
| 华安证券 | 2024-11-06 | 买入 | 买入 |
| 野村东方国际证券 | 2024-11-04 | 中性 | |
| 东吴证券 | 2024-11-03 | 买入 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"17.24","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"23.23","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"25.24","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"33.59","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"38.38","blueLineValue":"0.41","type":"YC"}]